Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrave for weight recurrence after laparoscopic sleeve gastrectomy
TCTR20261024002Phase 4Completed
- Sponsor
- iNova Pharmaceuticals
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone + bupropion in obesity, sponsored by iNova Pharmaceuticals. Started Oct 2025; status: completed.
02
Drugs
naltrexone + bupropion
03
Conditions
obesity
Beyond the preview
Go deeper on TCTR20261024002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261024002.